FOLR2 and lung carcinoma: We found that FRα could not be used as a predictor of lung cancer prognosis (p = 0.356, 95% CI 0.788–1.938), whereas FRβ could be used as an independent predictor of lung cancer prognosis (p = 0.000, 95% CI 1.794–4.913).